# Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects

> **NCT03363984** · PHASE1 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Midazolam
- **DRUG:** ID-082

## Key facts

- **NCT ID:** NCT03363984
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-27
- **Primary completion:** 2017-12-19
- **Final completion:** 2017-12-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03363984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03363984, "Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03363984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*